Jim Cramer: Boston Scientific Stock Is Too Hard to Own

Jim Cramer, host of CNBC's Mad Money, expressed surprise at the sharp decline in Boston Scientific Corporation (NYSE:BSX) stock, describing it as "too hard to own" in the current environment. His comments came in response to a caller asking about his view on the stock.

Details

Cramer noted that Iran peace negotiations could trigger an oil glut, cool inflation, and pull interest rates down. This scenario could impact the healthcare sector broadly, including companies like Boston Scientific. He added: "Now, I gotta tell you something, I was shocked at the decline…" without finishing the sentence, indicating the drop was larger than expected.

Context

The statement comes amid volatility in the healthcare sector due to changing interest rate expectations and economic outlook. Boston Scientific had performed strongly in recent years but has faced selling pressure recently.

What It Means for Investors

Cramer's comments reflect caution toward the stock amid economic uncertainty. Investors are advised to monitor interest rate and oil price developments, as they could directly impact the company's performance.